Quaglia, F. M. (2019) “Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation”, Mediterranean Journal of Hematology and Infectious Diseases, 11(1), p. e2019057. doi: 10.4084/mjhid.2019.057.